Application of Nanoliposome Alprostadil in the Perioperative Period of Percutaneous Coronary Intervention to Reduce In-Stent Restenosis: A Systematic Review and Meta-Analysis

Figure 2

Quality and risk of bias assessment of the included studies. Risk of bias in each study (a); the summarized result (b) (figure created by Review Manager Software version 5.3, The Nordic Cochrane Centre, and The Cochrane Collaboration, 2014).

(a)

(b)